Hytrin and Monocyte morphology abnormal - from FDA reports
There is no Monocyte morphology abnormal reported by people who take Hytrin yet. This review analyzes which people have Monocyte morphology abnormal with Hytrin. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Aug, 24, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Monocyte morphology abnormal when taking Hytrin?
- Check symptoms - is monocyte morphology abnormal caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Join related support groups - you are not alone, join a support group on ehealth.me
- Report the side effect - help people in need and in real time
- More tools...
Expand the study to include all drugs with the same ingredientsMonocyte morphology abnormal and drugs with ingredients of terazosin hydrochloride.
Expand the study to include reports from both FDA and eHealthMeMonocyte morphology abnormal and Hytrin from FDA and eHealthMe reports
Hytrin has active ingredients of terazosin hydrochloride. It is often used in prostate examination abnormal. (latest outcomes from Hytrin 6,854 users)
Monocyte Morphology Abnormal
Monocyte morphology abnormal has been reported by people with fungal infection (latest reports from 12 Monocyte morphology abnormal patients).